We are pleased to announce that we have launched a unique research project in conjunction with Queen Mary University of London.The Knowledge Transfer Partnership (KTP) sponsored by the Department of Trade and Industry (DTI), and Richmond Pharmacology Ltd is a two year project bringing together academia and commercial expertise.The project will culminate in the development of unique software tools, which will allow for the collection and linking of data from different medical measurement devices into one central repository for analysis.Dr Dilshat Djumanov PhD, a Research Associate from Queen Mary University of London, will undertake this two year research project.Dr Dilshat Djumanov Commented The Knowledge Transfer Partnership gives me the opportunity to undertake a demanding and exciting work based project, in which the results will be implemented in to a commercial environment. Working in conjunction with and having the support from Dr Peter Dabnichki Lecturer in Medical Engineering, Queen Mary University of London, and Dr Radivoj Arezina Research Director, Richmond Pharmacology, this 2 year project will offer Richmond Pharmacology expertise on data acquisition, data processing and software design to compliment and enhance the existing procedures.

Latest news

Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence

September 1, 2025
Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event